AMY THERIAULT: Open Payments
NPI 1295107977 · NORTH EAST, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,543 in 79 payments from 17 companies in 2025. Trend: 2023 $512 · 2024 $1,242 · 2025 $1,543
Food & beverage: $1,458Education: $85
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 11 | $258 |
| ABBVIE INC. | 13 | $211 |
| AstraZeneca Pharmaceuticals LP | 9 | $174 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $172 |
| Lilly USA, LLC | 9 | $142 |
| Amgen Inc. | 9 | $136 |
| Novo Nordisk Inc | 5 | $120 |
| PFIZER INC. | 5 | $92 |
| Exact Sciences Corporation | 2 | $62 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
Products named: Veozah, Kerendia, MOUNJARO, FARXIGA, Ozempic, OTEZLA, UBRELVY, QULIPTA.
Industry payments across MD — which companies pay providers there.
